Seco-cyclic phorbol derivatives and their anti-HIV-1 activities

Xiaolei HUANG , Xusheng HUANG , Qirun LI , Mengdi MA , Yadong CUI , Liumeng YANG , Haibo WANG , Ronghua LUO , Jinglei CHEN , Jingxuan YANG , Jinrong LIN , Duxin LI , Yongtang ZHENG , Jian ZHANG

Chinese Journal of Natural Medicines ›› 2024, Vol. 22 ›› Issue (4) : 365 -374.

PDF (1207KB)
Chinese Journal of Natural Medicines ›› 2024, Vol. 22 ›› Issue (4) :365 -374. DOI: 10.1016/S1875-5364(24)60630-8
Original article
research-article
Seco-cyclic phorbol derivatives and their anti-HIV-1 activities
Author information +
History +
PDF (1207KB)

Abstract

Phorbol esters are recognized for their dual role as anti-HIV-1 agents and as activators of protein kinase C (PKC). The efficacy of phorbol esters in binding with PKC is attributed to the presence of oxygen groups at positions C20, C3/C4, and C9 of phorbol. Concurrently, the lipids located at positions C12/C13 are essential for both the anti-HIV-1 activity and the formation of the PKC-ligand complex. The influence of the cyclopropane ring at positions C13 and C14 in phorbol derivatives on their anti-HIV-1 activity requires further exploration. This research entailed the hydrolysis of phorbol, producing seco-cyclic phorbol derivatives. The anti-HIV-1 efficacy of these derivatives was assessed, and the affinity constant (Kd) for PKC-δ protein of selected seco-cyclic phorbol derivatives was determined through isothermal titration calorimetry. The findings suggest that the chemical modification of cyclopropanols could affect both the anti-HIV-1 activity and the PKC binding affinity. Remarkably, compound S11, with an EC50 of 0.27 μmol·L−1 and a CC50 of 153.92 μmol·L−1, demonstrated a potent inhibitory effect on the intermediate products of HIV-1 reverse transcription (ssDNA and 2LTR), likely acting at the viral entry stage, yet showed no affinity for the PKC-δ protein. These results position compound S11 as a potential candidate for further preclinical investigation and for studies aimed at elucidating the pharmacological mechanism underlying its anti-HIV-1 activity.

Keywords

seco-Cyclic phorbol derivatives / Hydrolysis reaction / Cyclopropane ring / Esterification / Anti-HIV-1 agent

Cite this article

Download citation ▾
Xiaolei HUANG, Xusheng HUANG, Qirun LI, Mengdi MA, Yadong CUI, Liumeng YANG, Haibo WANG, Ronghua LUO, Jinglei CHEN, Jingxuan YANG, Jinrong LIN, Duxin LI, Yongtang ZHENG, Jian ZHANG. Seco-cyclic phorbol derivatives and their anti-HIV-1 activities. Chinese Journal of Natural Medicines, 2024, 22(4): 365-374 DOI:10.1016/S1875-5364(24)60630-8

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Browne E, Kavanagh S, Devery S. The cytotoxicity of phorbol 12-myristate 13-acetate and lipopolysaccharide on THP-1 cells and an optimized differentiation protocol[J]. Med Sci Forum, 2022, 11(1): 5.

[2]

Chen H, Zhang R, Luo RH, et al. Anti-HIV activities and mechanism of 12-O-tricosanoylphorbol-20-acetate, a novel phorbol ester from Ostodes katharinae[J]. Molecules, 2017, 22(9): 1498.

[3]

Lee HK, Kim HS, Pyo M, et al. Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in mice[J]. Theranostics, 2020, 10(22): 10186-10199.

[4]

Wang HB, Wang XY, Liu LP, et al. Tigliane diterpenoids from the Euphorbiaceae and Thymelaeaceae families[J]. Chem Rev, 2015, 115(9): 2975-3011.

[5]

Gulakowski RJ, McMahon JB, Buckheit RW, et al. Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV)[J]. Antivir Res, 1997, 33(2): 87-97.

[6]

Beans EJ, Fournogerakis D, Gauntlett C, et al. Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo[J]. PNAS, 2013, 110(29): 11698-11703.

[7]

Li QR, Zhang XQ, Cui XJ, et al. Optimization of preparation process of phorbol and synthesis, characterization and cytotoxicity of its derivatives[J]. Nat Prod Res Dev, 2019, 31: 1091-1100.

[8]

Li QR, Cheng YY, Zhao L, et al. New phorbol ester derivatives as potent anti-HIV agents[J]. Bioorg Med Chem Lett, 2021, 50: 128319.

[9]

Ma QG, Liu WZ, Wu XY, et al. Diterpenoids from Euphorbia Fischeriana[J]. Phytochemistry, 1997, 44(4): 663-666.

[10]

Zhang DD, Zhou B, Yu JH, et al. Cytotoxic tigliane-type diterpenoids from Croton tiglium[J]. Tetrahedron, 2015, 71(52): 9638-9644.

[11]

Abdel-Hafez AA, Nakamura N, Hattori M. Biotransformation of phorbol by human intestinal bacteria[J]. Chem Pharm Bull, 2002, 50(2): 160-164.

[12]

Yu TZ, Sun Y, Tu CH, et al. Total synthesis of crotophorbolone[J]. Chem Sci, 2020, 11(27): 7177-7181.

[13]

Bartsch H, Hecker E. Zur chemie des phorbols, XII: phorbobutanon[J]. Z Naturforsch B, 1969, 24(1): 99-106.

[14]

Thielmann HW, Hecker E. Zur chemie des phorbols, XIV: Die Flaschenträger-Reaktion[J]. Liebigs Ann Chem, 1969, 728(1): 158-183.

[15]

DePuy CH, Breitbeil FW, DeBruin KR. Chemistry of cyclopropanols. V. stereochemistry of acid- and base-catalyzed ring opening 1,2[J]. J Am Chem Soc, 1966, 88(14): 3347-3354.

[16]

Wang RR, Gao YD, Ma CH, et al. Mangiferin, an anti-HIV agent targeting protease effective against resistant strains[J]. Molecules, 2011, 16(5): 4264-4277.

[17]

Tan CJ, Li SF, Huang N, et al. Daphnane diterpenoids from Trigonostemon lii and inhibition activities against HIV-1[J]. Nat Prod Bioprospect, 2020, 10(1): 37-44.

[18]

Leavitt S, Freire E, Direct measurement of protein binding energetics by isothermal titration calorimetry[J]. Curr Opin Struc Biol, 2001, 11(5): 560-566.

Funding

National Natural Science Foundation of China(81202882)

National Natural Science Foundation of China(82060670)

Suzhou Science and Technology Planning Project in Jiangsu Province of China(SNG2021022)

Priority Academic Program Development of the Jiangsu Higher Education Institutes, China(PAPD)

Project of Innovative Research Team of Yunnan Province(202005AE160005)

PDF (1207KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/